DADC
NPSP

D.A. Davidson & Co’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

D.A. Davidson & Co’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-5,558
Closed -$182K – 2245
2014
Q2 		$182K Sell
5,558
-76
-1% -$2.19K 0.01% 932
2014
Q1 		$166K Sell
5,634
-430
-7% -$14.8K 0.01% 946
2013
Q4 		$183K Sell
6,064
-104
-2% -$2.86K 0.01% 860
2013
Q3 		$195K Sell
6,168
-41
-0.7% -$941 0.01% 708
2013
Q2 		$93K Buy
+6,209
New +$86K ﹤0.01% 897

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.A. Davidson & Co's NPSP Position: Q3 2014 in Review

D.A. Davidson & Co sold out of NPS PHARMACEUTICALS INC (NPSP) in Q3 2014, closing a stake of 5,558 shares — an estimated $182K sold.

D.A. Davidson & Co first reported a position in NPSP in Q2 2013 and held it in 5 quarters. The position peaked at $195K in Q3 2013. 200 funds tracked by Wall St. Rank hold NPSP as of Q3 2014.

  • D.A. Davidson & Co reported no remaining NPS PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • D.A. Davidson & Co sold 5,558 NPS PHARMACEUTICALS INC shares in Q3 2014, an estimated $182K.
  • D.A. Davidson & Co first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • D.A. Davidson & Co's NPS PHARMACEUTICALS INC position peaked at $195K in Q3 2013.
  • 200 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q3 2014.

Based on D.A. Davidson & Co's 13F filing for Q3 2014, filed 12 Nov 2014.